Clearmind Medicine Inc.
22.3M
$0.12M
-1.05
$-30.34
No price alerts set. Add an alert to get notified!
-1.05
3.39
$-30.34
-323.41%
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
CANF
Can-Fite BioPharma Ltd.
|
$3.05 | 4.45% | -769.91 | $2.60M | 0.01 |
|
CLDI
Calidi Biotherapeutics, Inc.
|
$0.27 | -4.40% | -0.10 | $1.98M | 0.52 |
|
CNSP
CNS Pharmaceuticals, Inc.
|
$2.64 | 5.18% | -0.07 | $1.52M | 0.07 |
|
GRI
GRI Bio, Inc.
|
$2.44 | 1.67% | -0.10 | $219,190 | 0.01 |
|
JAGX
Jaguar Health, Inc.
|
$0.41 | 4.10% | -0.02 | $947,004 | -2.52 |
|
KZIA
Kazia Therapeutics Limited
|
$9.46 | 5.23% | -1.86 | $15.32M | 0.00 |
|
SILO
Silo Pharma, Inc.
|
$0.40 | -7.17% | -1.26 | $3.20M | 0.00 |
|
SNGX
Soligenix, Inc.
|
$1.15 | 0.00 | -0.53 | $11.85M | 0.07 |
|
TTNP
Titan Pharmaceuticals, Inc.
|
$2.34 | -11.36% | 27.57 | $3.11M | 0.04 |
|
XBIO
Xenetic Biosciences, Inc.
|
$3.26 | 4.82% | -2.79 | $5.55M | 0.00 |
* Peer stocks are selected based on market capitalization and sector
$52.40
$0.60
$0.00
0.00%
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.
